Search Results - "Matzinger, O"

Adjuvant chemoradiation for gastric carcinoma: State of the art and perspectives by Schernberg, A., Rivin del Campo, E., Rousseau, B., Matzinger, O., Loi, M., Maingon, P., Huguet, F.

“…•Debates persist between the superiority of perioperative chemotherapy or adjuvant chemoradiotherapy in the management of gastric adenocarcinoma.•This review…”
Get full text

Stereotactic body radiotherapy with helical TomoTherapy for medically inoperable early stage primary and second-primary non-small-cell lung neoplasm: 1-year outcome and toxicity analysis by Casutt, A, Bouchaab, H, Beigelman-Aubry, C, Bourhis, J, Lovis, A, Matzinger, O

“…This study investigated the effectiveness of stereotactic body radiotherapy with helical TomoTherapy (T-SBRT) for treating medically inoperable primary and…”
Get full text

Early-stage Favourable Anal Cancer: A Retrospective Analysis of Clinical Outcomes of a Moderately Low Dose Elective Nodal Intensity-modulated Radiotherapy Schedule by Lestrade, L, Zilli, T, Kountouri, M, Jumeau, R, Matzinger, O, Bourhis, J, Miralbell, R, Ozsahin, M, De Bari, B

“…Abstract In this retrospective study we evaluated the long-term results of 35 early-stage favourable T1-2 N0 M0 anal cancer patients treated with…”
Get full text

Safety and Efficacy of Image Guided Intensity Modulated Radiation Therapy in the Treatment of Anal Canal Cancer by De Bari, B, Lestrade, L, Jumeau, R, Kountouri, M, Matzinger, O, Bourhis, J, Miralbell, R, Zilli, T, Ozsahin, E.M

Get full text

Could Acute Toxicity Predict Tumor Regression Rate in Rectal Cancer Patients Undergoing Neoadjuvant Treatment? by Ozsahin, E.M, De Bari, B, Saidi, A, Hahnloser, D, Wagner, D, Yan, P, Matzinger, O, Bourhis, J

Get full text

Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991 by Matzinger, O, Duclos, F, Bergh, A. van den, Carrie, C, Villà, S, Kitsios, P, Poortmans, P, Sundar, S, van der Steen-Banasik, E.M, Gulyban, A, Collette, L, Bolla, M

“…Abstract Introduction This trial randomly assessed short-term adjuvant hormonal therapy added to radiotherapy (RT) for intermediate- and high-risk (UICC 1997…”
Get full text

PD-0359 RADIOSENSITIZING EFFECT OF A RASGAP DERIVED PEPTIDE ON CELL SURVIVAL IN HUMAN CANCER CELLS IN VITRO AND IN VIVO by Viertl, D, Annibaldi, A, Widmann, C, Matzinger, O

Get full text

Fish oil prevents the adrenal activation elicited by mental stress in healthy men by Delarue, J, Matzinger, O, Binnert, C, Schneiter, P, Chioléro, R, Tappy, L

“…A diet rich in n-3 fatty acids (fish oils) is associated with reduced risks of cardiovascular and metabolic diseases, but the mechanisms remain incompletely…”
Get full text

Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014) by Matzinger, O, Roelofsen, F, Mineur, L, Koswig, S, Van Der Steen-Banasik, E.M, Van Houtte, P, Haustermans, K, Radosevic-Jelic, L, Mueller, R.P, Maingon, P, Collette, L, Bosset, J.F

“…Abstract Purpose To assess the feasibility and activity of radio-chemotherapy with mitomycin C (MMC) and cisplatin (CDDP) in locally advanced squamous cell…”
Get full text

PO-0703: Safety and efficacy of image guided intensity-modulated radiation therapy in the treatment of anal canal cancer by De Bari, B, Lestrade, L, Jumeau, R, Kontouri, M, Matzinger, O, Bourhis, J, Zilli, T, Ozsahin, M

Get full text

PO-0899: Dosimetric evaluation of deliverable and navigated Pareto optimal plans generated with MCO by Moeckli, R, Kyroudi, A, Ghandour, S, Matzinger, O, Petersson, K, Ozsahin, M, Bourhis, J, Pachoud, M

Get full text

PO-0705: Could acute toxicity predict tumor regression rate in rectal cancer patients undergoing neoadjuvant treatment? by Ozsahin, E, De Bari, B, Saidi, A, Hanhloser, D, Wagner, D, Yan, P, Matzinger, O, Bourhis, J

Get full text

Helical Intensity Modulated Radiation Therapy With Daily Image Guidance in the Treatment of Anal Canal Cancer by De Bari, B, Bouchaab, H, Péguret, N, Matzinger, O, Vallet, V, Wagner, A, Hahnloser, D, Bourhis, J, Ozsahin, M

Get full text

105 A TAT-RASGAP DERIVED PEPTIDE EFFICIENTLY SENSITIZES CANCER CELLS TO RADIOTHERAPY, AN IN VITRO AND IN VIVO STUDY by Viertl, D, Annibaldi, A, Widmann, C, Matzinger, O

Get full text

EP-1304: Image guided intensity modulated radiotherapy for anal cancer: a multi institutional study by De Bari, B, Lestrade, L, Franzetti Pellanda, A, Jumeau, R, Kountouri, M, Matzinger, O, Corradini, N, Biggiogero, M, Ballerini, G, Bourhis, J, Miralbell, R, Ozsahin, M, Zilli, T

Get full text

213: Radiosensitizing effect of a RasGAP derived peptide on cell survival in human cancer cells in vitro and in vivo by Viertl, D, Annibaldi, A, Matzinger, O, Vozenin, M.-C, Widmann, C, Bourhis, J

Get full text

OC-09: TAT-RASGAP317-326 Abolishes in Vivo Radio-Resistance of P53 Defective Tumor by Viertl, D, Annibaldi, A, Özsahin, M, Widmann, C, Matzinger, O

Get full text

SU‐C‐141‐05: Impact of Respiratory‐Correlated CT Reconstruction Algorithms in the Choice of Margin Definition for Free Breathing Lung Treatment by Thengumpallil, S, Germond, J‐F, Matzinger, O, Bourhis, J, Bochud, F, Moeckli, R

“…Purpose: To investigate the impact of phase‐and amplitude‐based reconstruction algorithms in 4D treatment margin strategies in presence of respiratory…”
Get full text

SU‐E‐T‐46: Evaluation of Different Cancer Risk Models on Second Cancer Risk Calculation for Conventional Breast Cancer Radiation Therapy by Joosten, A, Bochud, F, Matzinger, O, Moeckli, R

“…Purpose: To determine the influence of different cancer risk models on second cancer risk when these models are applied to full‐body dose distribution of two…”
Get full text

Glioblastoma Expressing MGMT: Contribution of PaTrin-2 in Radiation Therapy With Temozolomide by Viertl, D, Perillo-Adamer, F, Buchegger, F, Matzinger, O, Rüegg, C, Mirimanoff, R

Get full text